Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.34USD
22 Aug 2014
Price Change (% chg)

$0.22 (+4.30%)
Prev Close
$5.12
Open
$5.14
Day's High
$5.41
Day's Low
$5.02
Volume
157,653
Avg. Vol
304,990
52-wk High
$7.45
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.47
Market Cap (Mil.): $356.12
Shares Outstanding (Mil.): 69.56
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): -- 33.74 34.44
EPS (TTM): -0.63 -- --
ROI: -31.70 18.86 18.11
ROE: -41.62 19.48 18.84
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks